The miracle drugs of tomorrow
The Clarivate Drugs to Watch report spotlights recently-launched or soon-to-launch drugs with the potential to change treatment paradigms and/or reach blockbuster status within five years.
From CRISPR to bispecifics, cancer to COPD,
new drugs on the cusp
The Clarivate Drugs to Watch report spotlights recently-launched or soon-to-launch drugs with the potential to change treatment paradigms and/or reach blockbuster status within five years.
A dozen new and emerging therapeutics with the potential to transform treatment paradigms and/or become blockbusters within the next five years, according to Clarivate data and predictive analytics.
Access global intelligence, advanced analytics and global experts from Clarivate.
